← Leaderboards
Srinivasan Beddhu
University Of Utah
$13,920,703
Attributed
$14,658,411
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,658,411 · 9
AHRQ$0 · 1
By mechanism
R01$13,695,821 · 6
R21$644,625 · 2
T35$317,965 · 1
R03$0 · 1
Top collaborators
- Glenn Matthew Chertow4 shared
- June Louise Round4 shared
Most similar at University Of Utah
Same institution · by research overlap
- Yan-Ting E. Shiu$4,275,511
- Alfred K. Cheung$14,284,841
- Jennifer Juhl Majersik$14,372,144
- David K Gaffney$7,144,579
- June Louise Round$12,932,112
Others in their field
Top investigators on “Cardiovascular Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,558,149
- Judith S. Currier · University Of California Los Angeles$143,001,230
- David M Nathan · Massachusetts Institute Of Technology$141,671,512
- John M Lachin · George Washington University$139,991,329
- Judith S Hochman · New York University School Of Medicine$112,514,057
Research focus
Cardiovascular DiseasesParticipantDiabetes MellitusMetabolicInflammationWalkingCessation Of LifeObesityMortalityFundingOxidative StressAlzheimer&AposRisk FactorsKidney DiseasesCardiovascular SystemCardiovascular Risk FactorInflammatory MarkerIncidenceChronic Kidney FailureEventUtahRandomizedSerumCohort
Grant awards (38)
Sit Less, Interact and Move More (SLIMM) 2 Study$635,572
R01 · FY2025 · DK · contact PI
Objectively Measured Sedentary Behavior and Physical Activity in PREVENTABLE Study$518,733
R01 · FY2025 · AG · contact PI
MSRP in Metabolism, Diabetes, Digestive and Kidney Diseases$72,442
T35 · FY2025 · DK · contact PI
Objectively Measured Sedentary Behavior and Physical Activity in PREVENTABLE Study$710,169
R01 · FY2024 · AG · contact PI
Sit Less, Interact and Move More (SLIMM) 2 Study$622,600
R01 · FY2024 · DK · contact PI
MSRP in Metabolism, Diabetes, Digestive and Kidney Diseases$88,771
T35 · FY2024 · DK · contact PI
Objectively Measured Sedentary Behavior and Physical Activity in PREVENTABLE Study$700,607
R01 · FY2023 · AG · contact PI
Sit Less, Interact and Move More (SLIMM) 2 Study$663,260
R01 · FY2023 · DK · contact PI
MSRP in Metabolism, Diabetes, Digestive and Kidney Diseases$78,133
T35 · FY2023 · DK · contact PI
Objectively Measured Sedentary Behavior and Physical Activity in PREVENTABLE Study$710,711
R01 · FY2022 · AG · contact PI
Sit Less, Interact and Move More (SLIMM) 2 Study$666,507
R01 · FY2022 · DK · contact PI
MSRP in Metabolism, Diabetes, Digestive and Kidney Diseases$78,619
T35 · FY2022 · DK · contact PI
Objectively Measured Sedentary Behavior and Physical Activity in PREVENTABLE Study$740,106
R01 · FY2021 · AG · contact PI
Sit Less, Interact and Move More (SLIMM) 2 Study$685,127
R01 · FY2021 · DK · contact PI
Long-term metabolic effects of kidney events with intensive SBP control$277,543
R01 · FY2021 · DK · contact PI
Long-term metabolic effects of kidney events with intensive SBP control$279,090
R01 · FY2020 · DK · contact PI
Influence of baseline DBP on the effects of BP lowering on clinical outcomes: A participant level meta-analysis of RCTs$114,375
R21 · FY2020 · HL · contact PI
Long-term metabolic effects of kidney events with intensive SBP control$295,819
R01 · FY2019 · DK · contact PI
Influence of baseline DBP on the effects of BP lowering on clinical outcomes: A participant level meta-analysis of RCTs$114,375
R21 · FY2019 · HL · contact PI
Long-term metabolic effects of kidney events with intensive SBP control$305,000
R01 · FY2018 · DK · contact PI
Sit Less, Interact, Move More (SLIMM) intervention for sedentary behavior in CKD$189,375
R21 · FY2017 · DK · contact PI
Sit Less, Interact, Move More (SLIMM) intervention for sedentary behavior in CKD$226,500
R21 · FY2016 · DK · contact PI
SPRINT - Factors Affecting Atherosclerosis Study (FAST)$505,203
R01 · FY2014 · DK · contact PI
SPRINT - Factors Affecting Atherosclerosis Study (FAST)$524,922
R01 · FY2013 · DK · contact PI
SPRINT - Factors Affecting Atherosclerosis Study (FAST)$598,650
R01 · FY2012 · DK · contact PI
SPRINT - Factors Affecting Atherosclerosis Study (FAST)$658,522
R01 · FY2011 · DK · contact PI
Adipokines in Hemodialysis Patients$553,439
R01 · FY2011 · DK · contact PI
Protein intake, nutrition and cardiovascular disease in stage V CKD$264,868
R01 · FY2011 · DK · contact PI
Adipokines in Hemodialysis Patients$538,459
R01 · FY2010 · DK · contact PI
Protein intake, nutrition and cardiovascular disease in stage V CKD$289,905
R01 · FY2010 · DK · contact PI
Adipokines in Hemodialysis Patients$529,668
R01 · FY2009 · DK · contact PI
Protein intake, nutrition and cardiovascular disease in stage V CKD$296,871
R01 · FY2009 · DK · contact PI
Protein intake, nutrition and cardiovascular disease in stage V CKD$1,505
R01 · FY2009 · DK · contact PI
Adipokines in Hemodialysis Patients$553,278
R01 · FY2008 · DK · contact PI
Protein intake, nutrition and cardiovascular disease in stage V CKD$278,659
R01 · FY2008 · DK · contact PI
Protein intake, nutrition and cardiovascular disease in stage V CKD$291,028
R01 · FY2007 · DK · contact PI
Comorbidity, Costs and Outcomes in Dialysis Patients$0
R03 · FY2002 · HS
Comorbidity, Costs and Outcomes in Dialysis Patients$0
R03 · FY2001 · HS